FDA Issues EUA For First Test That Identifies Coronavirus Strains
Executive Summary
The US FDA announced two emergency use authorizations (EUAs) on 13 June. The first went to Laboratory Corporation of America for its test that detects lineages of SARS-CoV-2, the coronavirus that causes COVID-19,while the second went to to InspectIR Systems for its diagnostic that detects the virus from the breath.
You may also be interested in...
ITC Ruling Hands AliveCor Big Win Against Tech Giant
A judge with the US International Trade Commission sided with AliveCor in its ongoing feud with Apple, finding that the tech giant infringed on AliveCor’s patented electrocardiogram technology. The initial ruling sets up a full ITC review later this year.
Class I Recall For GE Healthcare CARESCAPE Ventilator
The US FDA has designated GE Healthcare’s recall of its CARESCAPE R860 ventilator as Class I, the agency’s most serious category.
Novel VR Treatment For Mental Illness Gets FDA Breakthrough
The US FDA has granted its breakthrough designation to a virtual reality therapy that recreates everyday scenarios for patients dealing with severe anxiety and schizophrenia.